CTOR
Citius Oncology, Inc.
1.10$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -57.7% | -10.4% | – | |
| – | – | – | – | – | – | – | – | – | – | -58.3% | +572.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -57.6% | -153.7% | – | |
| – | -0.3% | +17.5% | -16.1% | +14.6% | -2.4% | +148.3% | -70.1% | +14.7% | -5.4% | +6.0% | -79.8% | – | |
| – | -11.7% | -2.7% | +4.6% | +53.6% | -4.5% | -15.6% | -7.5% | -9.3% | +87.5% | +298.4% | -71.3% | – | |
| – | -9.1% | +2.4% | -1.3% | +44.1% | -4.1% | +16.8% | -33.8% | -4.7% | +78.4% | +256.3% | -73.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -64.4% | -20.0% | -27.9% | +1,145.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +83.5% | +0.0% | +0.0% | +0.0% | +0.0% | -187.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3,001.9% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.